HYTN Innovations Inc (HYTN)

Profile

TickerHYTN

RICHYTN.CD

ISINCA40443L1040

IssuerHYTN Innovations Inc

SectorEnergy

IndustryOil, Gas & Consumable Fuels

Sub-industryNon-Alcoholic Beverages

HeadquartersKelowna, Canada

Country of issuerCanada

Founded2015-08-08

Employees—

Total share float73,177,274

Holders (C/S)—

AuditorCrowe MacKay LLP

CEO / managementMr. Elliot Mckerr

Business Description

HYTN Innovations Inc. is a Canada-based pharmaceutical company. The Company is specialized in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids and psilocybe-derived tryptamines. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. Its product and services include GMP Cannabis Processing, GMP Psilocybin Mushroom Manufacturing, GMP Active Pharmaceutical Ingredient (API) Fabrication, Cannabis Consumer Packaged Goods, and Elevation Technology. The Company enables global market access for non-sterile pharmaceuticals. It has a manufacturing facility based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., 1306562 B.C. Ltd., and Prism Scientific Labs Inc.

ESG · Risk Indicators

Controversies score—

Governance pillar—

Social pillar—

Insider trading score—

Industry Substrate · Beverages + Food Products

Signals to watch

Geopolitical drivers

country_sugar_taxes_health_levies
tariffs_food_beverage_imports
russia_market_exit_food_beverage
climate_event_agricultural_supply_disruption
country_glp_1_uptake_demand_impact

Industry KPIs

Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.